Aurobindo Pharma Develops 14 Biosimilar Products

Aurobindo Pharma, a prominent player in the generic pharmaceutical industry, is significantly broadening its specialty

Read More

Aurobindo Pharma China Facility Set to Begin Production in Q3 FY25

Aurobindo Pharma anticipates initiating production at its new facility in China during the upcoming quarter,

Read More

USFDA Warns Aurobindo’s Eugia Pharma with a Warning Letter

Eugia Pharma Specialities, a fully owned subsidiary of Aurobindo Pharma, has recently received a warning

Read More

Aurobindo Pharma obtains marketing authorization for Trastuzumab Biosimilar in India

Aurobindo Pharma has achieved a significant milestone in its efforts to combat breast cancer with

Read More

Aurobindo’s TheraNym Biologics Signs Pact with MSD for Biologics Manufacturing

Aurobindo Pharma Limited has announced that its wholly-owned subsidiary, TheraNym Biologics Private Limited, has entered

Read More

Aurobindo Pharma reports increase in Q4 PAT

Aurobindo Pharma has announced a robust financial performance for the fourth quarter ending March 31,

Read More

Aurobindo Pharma’s Rajasthan Facility Wraps Up US FDA Audit with 9 Observations

Aurobindo Pharma, a leading pharmaceutical company, has announced the conclusion of a United States Food

Read More